The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies
The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ruffatti, Amelia [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values - Hedayati, Sara ELSEVIER, 2016transfer abstract, Philadelphia, Pa |
|---|---|
| Übergeordnetes Werk: |
volume:51 ; year:2021 ; number:1 ; pages:28-35 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.semarthrit.2020.10.001 |
|---|
| Katalog-ID: |
ELV053151682 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV053151682 | ||
| 003 | DE-627 | ||
| 005 | 20230624192452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.semarthrit.2020.10.001 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica |
| 035 | |a (DE-627)ELV053151682 | ||
| 035 | |a (ELSEVIER)S0049-0172(20)30286-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q VZ |
| 082 | 0 | 4 | |a 570 |q VZ |
| 082 | 0 | 4 | |a 570 |a 610 |q VZ |
| 084 | |a 58.30 |2 bkl | ||
| 084 | |a 50.22 |2 bkl | ||
| 084 | |a 44.09 |2 bkl | ||
| 100 | 1 | |a Ruffatti, Amelia |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. | ||
| 700 | 1 | |a Tonello, Marta |4 oth | |
| 700 | 1 | |a Favaro, Maria |4 oth | |
| 700 | 1 | |a Del Ross, Teresa |4 oth | |
| 700 | 1 | |a Calligaro, Antonia |4 oth | |
| 700 | 1 | |a Ruffatti, Alessandra Teresa |4 oth | |
| 700 | 1 | |a Gervasi, Maria Teresa |4 oth | |
| 700 | 1 | |a Hoxha, Ariela |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Saunders |a Hedayati, Sara ELSEVIER |t Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |d 2016transfer abstract |g Philadelphia, Pa |w (DE-627)ELV013670425 |
| 773 | 1 | 8 | |g volume:51 |g year:2021 |g number:1 |g pages:28-35 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.semarthrit.2020.10.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_181 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 936 | b | k | |a 58.30 |j Biotechnologie |q VZ |
| 936 | b | k | |a 50.22 |j Sensorik |q VZ |
| 936 | b | k | |a 44.09 |j Medizintechnik |q VZ |
| 951 | |a AR | ||
| 952 | |d 51 |j 2021 |e 1 |h 28-35 |g 8 | ||
| author_variant |
a r ar |
|---|---|
| matchkey_str |
ruffattiameliatonellomartafavaromariadel:2021----:hefccadaeyfeodieramnsfercoynohgrspennatpopoiisnrmptetaytmt |
| hierarchy_sort_str |
2021 |
| bklnumber |
58.30 50.22 44.09 |
| publishDate |
2021 |
| allfields |
10.1016/j.semarthrit.2020.10.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica (DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Ruffatti, Amelia verfasserin aut The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. Tonello, Marta oth Favaro, Maria oth Del Ross, Teresa oth Calligaro, Antonia oth Ruffatti, Alessandra Teresa oth Gervasi, Maria Teresa oth Hoxha, Ariela oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:51 year:2021 number:1 pages:28-35 extent:8 https://doi.org/10.1016/j.semarthrit.2020.10.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 51 2021 1 28-35 8 |
| spelling |
10.1016/j.semarthrit.2020.10.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica (DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Ruffatti, Amelia verfasserin aut The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. Tonello, Marta oth Favaro, Maria oth Del Ross, Teresa oth Calligaro, Antonia oth Ruffatti, Alessandra Teresa oth Gervasi, Maria Teresa oth Hoxha, Ariela oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:51 year:2021 number:1 pages:28-35 extent:8 https://doi.org/10.1016/j.semarthrit.2020.10.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 51 2021 1 28-35 8 |
| allfields_unstemmed |
10.1016/j.semarthrit.2020.10.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica (DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Ruffatti, Amelia verfasserin aut The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. Tonello, Marta oth Favaro, Maria oth Del Ross, Teresa oth Calligaro, Antonia oth Ruffatti, Alessandra Teresa oth Gervasi, Maria Teresa oth Hoxha, Ariela oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:51 year:2021 number:1 pages:28-35 extent:8 https://doi.org/10.1016/j.semarthrit.2020.10.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 51 2021 1 28-35 8 |
| allfieldsGer |
10.1016/j.semarthrit.2020.10.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica (DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Ruffatti, Amelia verfasserin aut The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. Tonello, Marta oth Favaro, Maria oth Del Ross, Teresa oth Calligaro, Antonia oth Ruffatti, Alessandra Teresa oth Gervasi, Maria Teresa oth Hoxha, Ariela oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:51 year:2021 number:1 pages:28-35 extent:8 https://doi.org/10.1016/j.semarthrit.2020.10.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 51 2021 1 28-35 8 |
| allfieldsSound |
10.1016/j.semarthrit.2020.10.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica (DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Ruffatti, Amelia verfasserin aut The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. Tonello, Marta oth Favaro, Maria oth Del Ross, Teresa oth Calligaro, Antonia oth Ruffatti, Alessandra Teresa oth Gervasi, Maria Teresa oth Hoxha, Ariela oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:51 year:2021 number:1 pages:28-35 extent:8 https://doi.org/10.1016/j.semarthrit.2020.10.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 51 2021 1 28-35 8 |
| language |
English |
| source |
Enthalten in Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values Philadelphia, Pa volume:51 year:2021 number:1 pages:28-35 extent:8 |
| sourceStr |
Enthalten in Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values Philadelphia, Pa volume:51 year:2021 number:1 pages:28-35 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Biotechnologie Sensorik Medizintechnik |
| institution |
findex.gbv.de |
| dewey-raw |
540 |
| isfreeaccess_bool |
false |
| container_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
| authorswithroles_txt_mv |
Ruffatti, Amelia @@aut@@ Tonello, Marta @@oth@@ Favaro, Maria @@oth@@ Del Ross, Teresa @@oth@@ Calligaro, Antonia @@oth@@ Ruffatti, Alessandra Teresa @@oth@@ Gervasi, Maria Teresa @@oth@@ Hoxha, Ariela @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV013670425 |
| dewey-sort |
3540 |
| id |
ELV053151682 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053151682</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624192452.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semarthrit.2020.10.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053151682</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-0172(20)30286-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.30</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.22</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.09</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ruffatti, Amelia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tonello, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Favaro, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Ross, Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calligaro, Antonia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruffatti, Alessandra Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gervasi, Maria Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoxha, Ariela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Hedayati, Sara ELSEVIER</subfield><subfield code="t">Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV013670425</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:51</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:28-35</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semarthrit.2020.10.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.30</subfield><subfield code="j">Biotechnologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.22</subfield><subfield code="j">Sensorik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.09</subfield><subfield code="j">Medizintechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">51</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield><subfield code="h">28-35</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Ruffatti, Amelia |
| spellingShingle |
Ruffatti, Amelia ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| authorStr |
Ruffatti, Amelia |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013670425 |
| format |
electronic Article |
| dewey-ones |
540 - Chemistry & allied sciences 570 - Life sciences; biology 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| topic |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
| topic_unstemmed |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
| topic_browse |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m t mt m f mf t d td a c ac a t r at atr m t g mt mtg a h ah |
| hierarchy_parent_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
| hierarchy_parent_id |
ELV013670425 |
| dewey-tens |
540 - Chemistry 570 - Life sciences; biology 610 - Medicine & health |
| hierarchy_top_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV013670425 |
| title |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| ctrlnum |
(DE-627)ELV053151682 (ELSEVIER)S0049-0172(20)30286-9 |
| title_full |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| author_sort |
Ruffatti, Amelia |
| journal |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
| journalStr |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
28 |
| author_browse |
Ruffatti, Amelia |
| container_volume |
51 |
| physical |
8 |
| class |
540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ruffatti, Amelia |
| doi_str_mv |
10.1016/j.semarthrit.2020.10.001 |
| dewey-full |
540 570 610 |
| title_sort |
efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. a systematic literature review analyzing 313 pregnancies |
| title_auth |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| abstract |
The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. |
| abstractGer |
The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. |
| abstract_unstemmed |
The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 |
| container_issue |
1 |
| title_short |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies |
| url |
https://doi.org/10.1016/j.semarthrit.2020.10.001 |
| remote_bool |
true |
| author2 |
Tonello, Marta Favaro, Maria Del Ross, Teresa Calligaro, Antonia Ruffatti, Alessandra Teresa Gervasi, Maria Teresa Hoxha, Ariela |
| author2Str |
Tonello, Marta Favaro, Maria Del Ross, Teresa Calligaro, Antonia Ruffatti, Alessandra Teresa Gervasi, Maria Teresa Hoxha, Ariela |
| ppnlink |
ELV013670425 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.semarthrit.2020.10.001 |
| up_date |
2024-07-06T18:09:14.049Z |
| _version_ |
1803854129713381376 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053151682</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624192452.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semarthrit.2020.10.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001306.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053151682</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-0172(20)30286-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.30</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.22</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.09</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ruffatti, Amelia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty. The study set out to evaluate the efficacy and safety of the second-line treatments most frequently used in addition to conventional therapy, and the data were analyzed to identify which is/are associated to the best pregnancy outcomes.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tonello, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Favaro, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Ross, Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calligaro, Antonia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruffatti, Alessandra Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gervasi, Maria Teresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoxha, Ariela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Hedayati, Sara ELSEVIER</subfield><subfield code="t">Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV013670425</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:51</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:28-35</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semarthrit.2020.10.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.30</subfield><subfield code="j">Biotechnologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.22</subfield><subfield code="j">Sensorik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.09</subfield><subfield code="j">Medizintechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">51</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield><subfield code="h">28-35</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.402525 |